CClinicalTrials.gg
RecruitingNCT06317181LivSPECTRUSUpdated Aug 20, 2025

Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data

An interventional study of Collection of elastography data and Collection of ultrasonic raw data in Artificial Intelligence, Ultrasonography and Elasticity Imaging Techniques, sponsored by Technische Universität Dresden. Recruiting at 4 sites in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-20.

Sponsored by Technische Universität Dresden · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to test the performance of neuronal networks trained on ultrasonic raw Data (=radiofrequency data) for the assessment of liver diseases in patients undergoing a clinical ultrasound examination. The general feasibility is currently evaluated in a retrospective cohort.

The main questions the study aims to answer are:

  • Can a neuronal network trained on RF Data perform equally good as elastography in the assessment of diffuse liver diseases?
  • Can a neuronal network trained on RF Data perform better than a neuronal network trained on b-mode images in the assessment of diffuse liver diseases?
  • Can a neuronal network trained on RF Data distinguish focal pathologies in the liver from healthy tissue?

To answer these questions participants with a clinically indicated fibroscan will undergo:

  • a clinical elastography in Case ob suspected diffuse liver disease
  • a reliable ground truth (if normal ultrasound is not sufficient e.g. contrast enhanced ultrasound, biopsy, MRI or CT) in case of focal liver diseases, depending on the standard routine of the participating center
  • a clinical ultrasound examination during which b-mode images and the corresponding RF-Data sets are captured
02

Conditions studied

  • Artificial Intelligence
  • Ultrasonography
  • Elasticity Imaging Techniques
  • Liver Diseases
  • Metastasis to Liver

Browse trials for

Keywords

  • Quantitative Ultrasound
  • Radiofrequency Data
03

In context

Liver Diseases

2,081 studies on the registry are indexed under Liver Diseases; 390 are open to participants now.

This study's planned enrollment of 200 is above the median of 50 across 1,323 interventional studies indexed under Liver Diseases.

Browse Liver Diseases studies →

Lead sponsor

Technische Universität Dresden is the lead sponsor of 237 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • scheduled for an ultrasound investigation by an independent physician
  • signed declaration of consent

Exclusion criteria

Exclusion Criteria:

  • smaller interventions in the same liver during the last 2 Week (for example liver biopsy)
  • contrast enhanced ultrasound less than a day ago
  • major intervention at the liver (for example partial resection)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Elastography

    Collection of ultrasound data and elastography data from patients who were clinically planned for elastography

    Device: Collection of elastography data

  • Experimental
    Focal lesion

    Collection of ultrasound data of the suspected lesion and a definitive diagnosis based on either normal ultrasound investigation or if not sufficient additional investigations like CEUS, Biopsy, MRI or CT. This further investigation should be in accordance to normal clinical routine of the centers to differentiate focal lesions.

    Device: Collection of ultrasonic raw data

Interventions

  • DeviceCollection of elastography data

    patients who are scheduled for an elastography for clinical reasons usually receive an ultrasound scan in which the b-mode images of the liver tissue are collected. In this study additional radiofrequency data is collected through a software access.

  • DeviceCollection of ultrasonic raw data

    Patients who are transferred to the ultrasound departement due to suspicious focal lesions receive an ultrasonic investigation including the acquisition of raw data and extracting a definitive diagnose from the following clinical routine investigation, depending on the standards of the participating center

06

What researchers measure

Primary outcomes

  1. Performance analysis of the trained model

    Analysis of the concordance of a Deep Learning-based analysis of RF data with established clinical measures. In case of diffuse disease the stiffness of the tissue and in case of the focal lesions the underlying disease as diagnosed by the local physicians are the measures. Performance is evaluated by the area under the receiver operating characteristic curve and a correlation coefficient.

    Time frame: After study completion, estimated 1 year

07

Study locations

4 of 4 sites recruiting
08

References and documents

Study documents

  • Study protocol · Mar 1, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — After the publication of data the anonymized IPD will be provided.

Supporting information: Study protocol, Sap, Icf, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06317181
Lead sponsor
Technische Universität Dresden
Collaborators
University Hospital Dresden, University of Leipzig
Responsible party
Moritz Herzog (Principal Investigator, Technische Universität Dresden) — Principal investigator
First posted
Mar 19, 2024
Start date
Apr 1, 2024
Primary completion
Oct 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Aug 20, 2025

Study contacts

Moritz Herzog, MD
Contact
moritz.herzog@ukdd.de
0049 351 458 11501
Moritz Herzog, MD
principal investigator · University Hospital Dresden

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion